Daniel J Lodge, Ph.D.
Professor & Chair
Currently seeking M.S. & Ph.D. students
In a broad sense, my laboratory is interested in better understanding the mechanisms underlying psychiatric disease with the goal of developing novel therapeutics. To do this we utilize a number of approaches including optogenetics, in vivo electrophysiology, behavioral and molecular methods. Using such an approach, we have identified what we believe to be a key pathology in schizophrenia, specifically a loss of interneuron function in the ventral hippocampus. This has led to a hypothesis that restoring interneuron function may be a novel therapeutic approach for schizophrenia. We are currently investigating the utility of stem cell derived interneuron transplants in rodent models of schizophrenia and autism.
-
Professional Background
Education
- 2003 - PhD - Medicine - Monash University
- 1998 - BSc Hons - Pharmacology (First Class Honors) - Monash University
Training
- 2009 - Postdoctoral Fellowship - Neuroscience - University of Pittsburgh
Appointments
- 3/2009 - 08/2015 - Assistant Professor - The University of Texas Health Science Center at San Antonio, Pharmacology, San Antonio
- 09/2015 - 08/2021 - Associate Professor - The University of Texas Health Science Center at San Antonio, Pharmacology, San Antonio
- 09/2021 - Professor - The University of Texas Health Science Center at San Antonio, Pharmacology, San Antonio
-
- Instruction & Training
- Research & Grants
- Service
- Publications